Edwin Rock Glycomimetics Inc (GLYC) insider trading activity

Edwin Rock is Chief Medical Officer of GLYCOMIMETICS INC. Currently has a direct ownership of 680,403 shares of GLYC, which is worth approximately $285,769. The most recent transaction as insider was on Jun 21, 2024, when has been sold 115,000 shares (Common Stock) at a price of $0.27 per share, resulting in proceeds of $31,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 680K

0% 3M change

81.25% 12M change

Total Value Held $285,769

Edwin Rock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 21 2024	BUY Open market or private purchase	$31,050 $0.27 p/Share	115,000 Added 14.46%	680,403 Common Stock
Jun 20 2024	BUY Open market or private purchase	$47,500 $0.25 p/Share	190,000 Added 25.15%	565,403 Common Stock
Sep 22 2023	BUY Open market or private purchase	$41,956 $1.38 p/Share	30,403 Added 7.49%	375,403 Common Stock
Sep 21 2023	BUY Open market or private purchase	$48,299 $1.38 p/Share	35,000 Added 9.21%	345,000 Common Stock
Dec 22 2022	BUY Open market or private purchase	$247,500 $2.25 p/Share	110,000 Added 26.19%	310,000 Common Stock
Nov 15 2022	BUY Open market or private purchase	$166,000 $1.66 p/Share	100,000 Added 33.33%	200,000 Common Stock
Nov 14 2022	BUY Open market or private purchase	$143,000 $1.43 p/Share	100,000 Added 50.0%	100,000 Common Stock

Edwin Rock

Chief Medical Officer

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLYC shares.

Notify only if

Value

Insider Trading

Get notified when an Glycomimetics Inc insider buys or sells GLYC shares.

Notify only if

Operation

Value

Type

News

Receive news related to GLYCOMIMETICS INC

Track Activities on GLYC

Account